IL-10 antibody

Catalog No. ABIN933786

This anti-IL-10 antibody is a Mouse Monoclonal antibody detecting IL-10 in WB, ELISA and Inhibition. Suitable for Human.

Quick Overview for IL-10 antibody (ABIN933786)

Target: IL-10 (IL10) (Interleukin 10 (IL10))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This IL-10 antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Blocking Antibody (Inhibition)

Clone: M912270

Product Details anti-IL-10 Antibody

Immunogen: IL10 antibody was raised in mouse using highly pure recombinant human IL-10 as the immunogen.

Isotype: IgG1 kappa

Application Details

Application Notes: Optimal conditions should be determined byt he investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized from PBS.

Handling Advice: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Storage: 4 °C/-20 °C

Storage Comment: Store at -20 °C until reconstitution. Following reconstitution product may be stored at 4 °C in the short term. For long term storage aliquot and freeze at -20 °C.

Target Details for IL-10

Target: IL-10 (IL10) (Interleukin 10 (IL10))

Alternative Name: IL10

Background: IL10 is an immunosuppressive cytokine produced by a variety of mammalian cell types including macrophages, monocytes, T cells, B cells and keratinocytes. IL10 inhibits the expression of proinflammatory cytokines such as IL1 and TNFa. Like IL4, IL10 enhances humoral immune responses and attenuates cell-mediated immune reactions. Human IL10 active on Mouse cells, but Mouse IL10 is inactive on human cells. Synonyms: Monoclonal IL10 antibody, Anti-IL10 antibody, IL-10 antibody, Interleukin 10 antibody, B-TCGF antibody, CSIF antibody, TGIF antibody.

Molecular Weight: 18.7 kDa (predicted detection band MW)

Pathways: Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Maintenance of Protein Location, Cancer Immune Checkpoints